By
SAN DIEGO — A broader range of autoantibodies may play a role in Sjogren’s syndrome than has previously been appreciated, researchers found.
Among 137 patients with primary Sjogren’s syndrome, as defined clinically by dry eye disease and positive lip biopsy, 74% had the typical anti-SSA and/or anti-SSB antibodies, while 6% had anti-centromere antibodies and 5% had anti-cyclic citrullinated peptide (CCP) antibodies, Alan Baer, MD, of Johns Hopkins University reported in a poster session here at the annual meeting of the American College of Rheumatology.
Jason Liebowitz, MD, completed his fellowship in rheumatology at Johns Hopkins University, Baltimore, where he also earned his medical degree. He is currently in practice with Skylands Medical Group, N.J.